RESEARCH-USE BIOSIMILAR ANTIBODY
Ormutivimab
Monoclonal antibody · IgG1
Ormutivimab (rhRIG) is a recombinant human monoclonal antibody, targeting rabies virus. Ormutivimab neutralizes a variety of rabies virus strains. Ormutivimab exhibits potent potency against rabies post-exposure prophylaxis (PEP) model.
TARGETRabies Virus Surface Glycoprotein 4 (gp4) Epitope 1
YMonoclonal antibody
CATALOGSC-BS-304
CATALOG NUMBERSC-BS-304
MOLECULAR WEIGHTApprox. 146.1 kDa
PRODUCT FORMATMonoclonal antibody
PRODUCT OVERVIEW
A research-use configuration for comparative antibody studies
Ormutivimab (rhRIG) is a recombinant human monoclonal antibody, targeting rabies virus. Ormutivimab neutralizes a variety of rabies virus strains. Ormutivimab exhibits potent potency against rabies post-exposure prophylaxis (PEP) model.
Ormutivimab is a recombinant research-use antibody directed against Rabies Virus Surface Glycoprotein 4 (gp4) Epitope 1.